Merit Medical Systems MMSI Acquisition Of Developed Technology In Accrued Expenses
Acquisition Of Developed Technology In Accrued Expenses at other companies
Other financials
Where this comes from
Reported directly by Merit Medical Systems in its filing.
Tagged under the XBRL concept mmsi:AcquisitionOfDevelopedTechnologyInAccruedExpenses.
The official record: Merit Medical Systems’s 10-Q, filed April 30, 2026, on SEC EDGAR. View the filing →
Ask your AI about Merit Medical Systems's acquisition of developed technology in accrued expenses.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Merit Medical Systems's acquisition of developed technology in accrued expenses?
- Merit Medical Systems (MMSI) reported acquisition of developed technology in accrued expenses of $2.94M in Q1 2026.
- How has Merit Medical Systems's acquisition of developed technology in accrued expenses changed year-over-year?
- Merit Medical Systems's acquisition of developed technology in accrued expenses decreased by 26.8% year-over-year, from $4.02M to $2.94M.
- What does acquisition of developed technology in accrued expenses mean?
- This represents the value of acquired intellectual property or developed technology that has been recognized as a liability rather than a direct cash payment during the period. It highlights non-cash investment activities where the company secures technological assets through deferred payment arrangements. Monitoring this helps investors identify off-balance-sheet financing or future cash obligations related to R&D and product expansion.